| Dr Ram Ron Miller, MD | |
|
5 Moore Dr, N2.3213, Research Triangle Park, NC 27709-0143 | |
| (919) 483-5832 | |
| (919) 315-2348 |
| Full Name | Dr Ram Ron Miller |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 5 Moore Dr, Research Triangle Park, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518929199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | D0062263 (Maryland) | Primary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 176218 (North Carolina) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ram Ron Miller, MD 5 Moore Dr, N2.3213, Research Triangle Park, NC 27709-0143 Ph: (919) 483-5832 | Dr Ram Ron Miller, MD 5 Moore Dr, N2.3213, Research Triangle Park, NC 27709-0143 Ph: (919) 483-5832 |
News Archive
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled "Methods of Improving the Pharmacokinetics of Doxepin."
Buffalo Hospital, Allina Medical Clinics and Buffalo Clinic are joining the ranks of many other health organizations, both local and nationwide, to become tobacco-free facilities.
Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, and could help to prevent up to one in four cases of HIV, according to a study published in The Lancet Infectious Diseases journal.
› Verified 4 days ago
Robert Dobbins, M.D., PH.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Moore Dr, Research Triangle Park, NC 27709 Phone: 919-483-7922 | |
Dr. Catherine Isaac, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Park Offices Dr Ste 140, Research Triangle Park, NC 27709 Phone: 919-425-5864 | |
David Phillips Siebens, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Moore Drive, Glaxosmithkline, Research Triangle Park, NC 27709 Phone: 919-483-4816 | |
Shepherd Schurman, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 Tw Alexander Dr, Bldg 109, Rm 108, Clinical Research Unit, Niehs, Nih, Research Triangle Park, NC 27709 Phone: 919-541-7736 Fax: 301-480-3416 |